MedTrace Logo

Evaluation of Bone Changes After Immediate Implant Placement or Socket Preservation With or Without Surgical Flap in The Aesthetic Zone

NCT03690973 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2021-08-05

No results posted yet for this study

Summary

The amount of hard tissue resorption following tooth extraction involves prosthetically driven implant placement; therefore, the development of ridge preservation techniques that result in less alveolar bone loss is of great interest, Alveolar ridge preservation are indicated to decrease the loss of ridge volume that follows tooth extraction.However, they do not prevent bone resorption because, depending on the technique.The protocol of placing implants immediately upon tooth extraction has been introduced into clinical practice which aims to preserve the socket from resorption, also immediate implant satisfy the patient as it decrease the time for crown insertion in addition to that it has a good survival.There is not adequate research data to clearly demonstrate that flapless socket preservation techniques are superior to techniques that involve raising a flap, but an animal study reported that the detachment of the periosteum from the buccal site of the ridge leads to an increase of the resorption rate, resulting in an increase of the ridge resorption

Conditions

  • Alveolar Socket Preservation

Interventions

DRUG

Alveolar socket preservation with graft and flap surgery

Alveolar socket preservation with xenogenic bone graft and flap surgery

DEVICE

Immediate implant placement with bone using flapless surgery

Immediate implant placement with xenogenic bone graft using flapless surgery

DEVICE

Immediate implant placement with bone using flap surgery

Immediate implant placement with xenogenic bone graft using flap surgery

DRUG

Alveolar socket preservation with graft and flapless surgery

Alveolar socket preservation with xenogenic bone graft and flapless surgery

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Amr Zahran, Phd · Cairo University

  • Ahmed Reda, Phd · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-30
Primary Completion
2020-12-30
Completion
2021-03-30
FDA Drug
Yes
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03690973 on ClinicalTrials.gov